A patient‐control group comparison revealed that, for the BC‐IAPS differential reactivity (Figure Group comparison between BC patients and controls in the neural BC‐IAPS differential reactivity. (A) Group comparison map of BC patients > controls. Yellow regions indicate where BC patients had greater activation for the BC‐IAPS differential reactivity than controls. (B) Neural activation (Within the patient group, there were no significant differences between the BMX and non‐BMX groups in the neural BC‐IAPS differential reactivity. There were no group differences between controls versus BC patients or BMX recipients versus non‐BMX recipients in other reactivity contrasts (Data 